Insulin-degrading enzyme inhibition, a novel therapy for type 2 diabetes?
- Author(s): Costes, Safia
- Butler, Peter C
- et al.
Published Web Locationhttp://www.sciencedirect.com/science/article/pii/S1550413114003246
The insulin-degrading enzyme (IDE) has been identified as a type 2 diabetes and Alzheimer's disease susceptibility gene, though its physiological function remains unclear. Maianti et al. (2014) now propose that an IDE inhibitor may be a promising therapeutic strategy for type 2 diabetes.